• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[成功切除一名重度甲型血友病且存在VIII因子抑制物患者的股骨假肿瘤]

[Successfull extirpation of femoral pseudotumour in a patient with severe haemophilia A and an inhibitor to factor VIII].

作者信息

Marisavljević D, Glisić M, Elezović I, Popović A, Rolović Z

出版信息

Srp Arh Celok Lek. 1991 Nov-Dec;119(11-12):338-42.

PMID:17974380
Abstract

The article deals with a successfull extirpation of femoral pseudotumour in a 53-year-old patient with severe haemophilia A (F VIII: C less than 1%) and an inhibitor to factor VIII. Such case is the first one reported in Yugoslavia. A combination of ultrasonography, computed axial tomography, angiography and Tc-99m labelled red blood cell scintigraphy was used for precise diagnosis of the pseudotumour. Preoperative preparation consisted of 50 units/kg of concentrate of F VIII (Hemate P) and 50 units/kg of activated prothrombine complex concentrate (FEIBA). A pseudotumour, 15 cm in diameter, was extirpated, as well as a few dauther cysts. F VIII concentrate was used for postoperative supportive therapy. On the 5-th postoperative day the patient prematurely rose from his bed and the "secondary bleeding" had to be treated with F VIII concentrate. The success of complex operations in haemophiliacs is possible only in big centres which can provide the best diagnostic procedures, trained surgeon teams, and modern and various supportive therapy.

摘要

本文报道了一例成功切除53岁重度甲型血友病(F VIII:C低于1%)且伴有VIII因子抑制物患者股骨假肿瘤的病例。此病例为南斯拉夫首例报道。联合应用超声、计算机断层扫描、血管造影和Tc-99m标记红细胞闪烁扫描术对假肿瘤进行精确诊断。术前准备包括每千克体重给予50单位的VIII因子浓缩物(血促性素)和每千克体重50单位的活化凝血酶原复合物浓缩物(FEIBA)。切除了一个直径15厘米的假肿瘤以及一些子囊肿。术后使用VIII因子浓缩物进行支持治疗。术后第5天,患者过早起床,出现“继发性出血”,不得不使用VIII因子浓缩物进行治疗。只有在能够提供最佳诊断程序、训练有素的外科团队以及现代多样支持治疗的大型中心,血友病患者进行复杂手术才有可能成功。

相似文献

1
[Successfull extirpation of femoral pseudotumour in a patient with severe haemophilia A and an inhibitor to factor VIII].[成功切除一名重度甲型血友病且存在VIII因子抑制物患者的股骨假肿瘤]
Srp Arh Celok Lek. 1991 Nov-Dec;119(11-12):338-42.
2
Surgery for a chronic cystic hematoma on the right thigh in a hemophiliac A with a potent factor VIII inhibitor.
Nihon Seikeigeka Gakkai Zasshi. 1982 Dec;56(12):1719-27.
3
Haemophilic pseudotumour of the mandible: report of three cases.下颌骨血友病性假瘤:三例报告
Int J Oral Maxillofac Surg. 2007 Jun;36(6):552-5. doi: 10.1016/j.ijom.2006.10.002. Epub 2007 Apr 27.
4
[Perioperative management of orthopaedic patients with hemophilia A].
Zhonghua Wai Ke Za Zhi. 2004 Dec 7;42(23):1430-3.
5
[Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
Acta Haematol Pol. 1994;25(4):349-54.
6
[Perioperative management of ventricular septal defect and right coronary cusp prolapse in a patient with hemophilia A].[甲型血友病患者室间隔缺损合并右冠状动脉瓣脱垂的围手术期管理]
Kyobu Geka. 1994 Dec;47(13):1071-4.
7
Pelvic haemophilic pseudotumour occurring in a patient with mild haemophilia: a brief report.轻度血友病患者发生盆腔血友病性假瘤:简要报告
Blood Coagul Fibrinolysis. 1990 Dec;1(6):747-8.
8
Successful combination therapy of a proximal haemophilic pseudotumour with surgery, radiation and embolization in a child with mild haemophilia A.一名患有轻度甲型血友病的儿童近端血友病性假肿瘤通过手术、放疗和栓塞进行成功的联合治疗。
Haemophilia. 2007 Mar;13(2):209-12. doi: 10.1111/j.1365-2516.2006.01425.x.
9
Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
Thromb Haemost. 1979 Feb 15;40(3):478-85.
10
[Kidney transplantation in a patient with haemophilia A].[一名甲型血友病患者的肾移植]
Transfus Clin Biol. 2009 Nov-Dec;16(5-6):471-3. doi: 10.1016/j.tracli.2009.09.003. Epub 2009 Oct 30.

引用本文的文献

1
Hemophilic Pseudotumors: Diagnosis and Management.血友病性假肿瘤:诊断与管理
Arch Bone Jt Surg. 2020 Mar;8(2):121-130. doi: 10.22038/abjs.2019.40547.2090.